🔗 Share this article

Treasury head Reeves has revealed she is preparing "specific measures to tackle cost of living pressures" in the upcoming Budget.

In comments to media outlets, she emphasized that reducing inflation is a joint duty of both the administration and the central bank.

The UK's inflation rate is projected to be the most elevated among the G7 advanced economies this year and next.

Possible Utility Bill Measures

Reports indicate the administration could take action to bring down energy bills, for instance by slashing the current 5% level of VAT applied on energy.

Another option is to cut some of the regulatory levies currently included in bills.

Budgetary Constraints and Analyst Expectations

The government will obtain the latest report from the official forecaster, the OBR, on the start of the week, which will show how much room there is for such measures.

The expectation from the majority of analysts is that Reeves will have to announce higher taxes or budget cuts in order to adhere to her declared debt limits.

Previously on Thursday, calculations indicated there was a twenty-two billion pound gap for the Treasury chief to address, which is at the lower end of expectations.

"It is a shared responsibility between the central bank and the government to bear down further on some of the sources of price increases," the Chancellor told the BBC in the US capital, at the conferences of the International Monetary Fund and World Bank.

Revenue Pledges and International Issues

While a great deal of the attention has been on probable tax increases, the chancellor said the latest data from the OBR had not altered her pledge to election pledges not to increase rates on earnings tax, VAT or National Insurance.

She attributed an "unpredictable world" with rising geopolitical and trade tensions for the Budget revenue measures, likely to be focused on those "wealthiest."

International Economic Disputes

Referring to worries about the UK's trade ties with China she said: "Our national security invariably are paramount."

Last week's announcement by Chinese authorities to increase export controls on critical minerals and other resources that are crucial for high-technology production led American leader Donald Trump to propose an extra 100% import tax on imports from China, raising the prospect of an full-scale trade war between the two global powers.

The American finance chief called the Chinese action "economic coercion" and "a international production power grab."

Questioned on considering the American proposal to participate in its dispute with the Asian nation, Reeves said she was "deeply worried" by Chinese actions and encouraged the Chinese government "to avoid restrictions and limit trade."

She said the move was "damaging for the international commerce and causes additional headwinds."

"In my view there are fields where we need to address Chinese policies, but there are also valuable prospects to trade with Chinese markets, including financial services and other sectors of the economy. We've got to maintain that balance right."

The chancellor also stated she was working with international partners "regarding our own critical minerals plan, so that we are more independent."

Health Service Drug Pricing and Funding

The Chancellor also admitted that the price the National Health Service pays for drugs could go up as a consequence of ongoing talks with the US government and its pharmaceutical firms, in return for reduced taxes and investment.

A number of the biggest global drug companies have said lately that they are either delaying or scrapping investments in the UK, with some attributing the insufficient payments they are getting.

Recently, the government science advisor said the cost the NHS pays for drugs would need to rise to halt businesses and pharmaceutical investment departing from the United Kingdom.

The Chancellor stated to the BBC: "We have seen as a result of the cost structure, that clinical trials, new drugs have not been available in the United Kingdom in the extent that they are in other EU nations."

"The objective is to guarantee that individuals getting treatment from the National Health Service are can obtain the best critical drugs in the globe. And so we are looking at this situation, and... aiming to attract more investment into Britain."